KDM1A and melanoma: IRF3 is required for T cell effector function52 to promote IFNγ-induced antitumor immunity to melanoma.53 IRF3 also inhibits colorectal54 and gastric cancer.55 These studies are consistent with our finding that LSD1 inhibition promotes IRF3 expression in OSCC cells.